Families with Pride Program for Substance Use and Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special program, Families with Pride ("Familias con Orgullo"), can help Hispanic sexual minority youth reduce drug use and ease depression. The program includes group sessions for parents and adolescents to enhance family support and reduce stress. It targets families in South Florida with Hispanic teens, aged 13-19, who identify as gay, lesbian, or bisexual and have shared this with at least one parent.
As an unphased trial, participants contribute to valuable research that may enhance support for Hispanic sexual minority youth.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this parenting intervention is safe for Hispanic sexual minority youth?
Research has shown that the Families with Pride program, also known as Familias con Orgullo, may help reduce drug use and feelings of depression among Latinx youth who identify as sexual minorities. An earlier study found that this family-focused program improved family cooperation.
Regarding safety, the program includes group sessions and family meetings, which do not carry the same risks as a medication trial. No reports of negative effects from the sessions themselves have emerged. Participants generally handle the program well without any problems.12345Why are researchers excited about this trial?
The Families with Pride program is unique because it combines group sessions for both parents and adolescents, along with family sessions, to address substance use and depression. Unlike traditional individual therapy or medication, this program emphasizes family dynamics and the role of supportive relationships in recovery. Researchers are excited about this approach because it seeks to foster a more holistic and inclusive environment for change, which could lead to more sustainable outcomes for both parents and adolescents dealing with these challenges.
What evidence suggests that the Families with Pride program is effective for reducing substance use and depression?
Research has shown that the "Families with Pride" (Familias con Orgullo) program, which participants in this trial may receive, may benefit Hispanic LGBTQ+ youth. A small study found that it could lower drug use and reduce feelings of depression in these young people. The program also aims to enhance family cooperation, fostering a more supportive home environment. Early results suggest it can increase parental support and make families more accepting. These positive changes likely reduce stress for both parents and teens. Overall, initial studies highlight the program's potential to improve well-being in the community.14678
Who Is on the Research Team?
Guillermo Prado, PhD
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for Hispanic sexual minority youth aged 13-17 living in South Florida who have disclosed their status to a parent. It's open to families where at least one parent identifies as Hispanic and agrees to participate. Families planning to move from South Florida or transgender adolescents are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the Families with Pride (Familias con Orgullo) intervention, consisting of seven multi parent group sessions, three multi adolescent group sessions, and four family sessions over 12 weeks
Community Practice
Participants receive standard of care services for up to 12 weeks
Follow-up
Participants are monitored for changes in drug use, depression symptoms, and family functioning
What Are the Treatments Tested in This Trial?
Interventions
- Families with Pride ("Familias con Orgullo")
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator